Clinical Trial

To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip Arthroplasty

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 13, 2025 (before its estimated November 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a phase IIa, multicenter ,randomized, double-blind, placebo-controlled study designed to evaluate the safety, efficacy and kinetic characteristics of TRD205 tablets for postoperative analgesia after unilateral hip arthroplasty
Trial Details
NCT Number NCT07121101
Lead Sponsor Beijing Tide Pharmaceutical Co., Ltd
Collaborators: The Third Affiliated Hospital of Southern Medical University
Conditions Postoperative Analgesia After Unilateral Hip Arthroplasty
Enrollment 40 participants
Start Date 2025-09-26
Primary Completion 2025-11-20 (estimated)
Study Completion 2025-12-27 (estimated)
Updated on ClinicalTrials.gov 2025-08-13